Two weeks ago, on January 13, 2021, to be precise, the President was the first person to receive a vaccine dose injection in a free mass vaccination program in Indonesia.
Source Biro Pers, Media, dan Informasi Sekretariat Presiden – Kementerian Sekretariat Negara
Media www.rajawalisiber.com – President Joko Widodo received a second injection of the Covid-19 vaccine on Wednesday, January 27, 2021, on the west side of the central courtyard of the Presidential Palace, Jakarta. Two weeks ago, on January 13, 2021, to be precise, the President was the first person to receive a vaccine dose injection in a free mass vaccination program in Indonesia.
Similar to the previous vaccination procedure, in this implementation, the President will still first carry out a number of stages. At around 08.25 WIB, the Head of State appeared to be occupying the registration table to validate the data. Furthermore, the Head of State also goes through the health screening stages, such as measuring body temperature, blood pressure, and examining medical history to ensure that vaccine recipients are in prime condition and fit to take vaccinations for this second dose.
Prof. dr. Abdul Muthalib, Sp.PD-KHOM. acting again as a vaccinator to President Joko Widodo. During the vaccination, the Deputy Chairperson of the Presidential Doctor was assisted by M. Sokheh, S.Kep., Ns. as Ners.
“Just like what was done two weeks ago, it was not felt (during the injection). In the past, after two hours there was only aches and pains, now I think it’s the same, ”said the President after receiving the injection of the second dose of the vaccine.
The vaccine that has been injected into the President and other vaccine recipients throughout Indonesia to date is the CoronaVac vaccine produced by Sinovac Life Science Co. Ltd. which in Indonesia collaborates with PT Bio Farma (Persero).
CoronaVac has secured an emergency use permit from the Food and Drug Administration (BPOM) after going through a number of clinical trials involving 1,620 volunteers in Bandung. The Indonesian Ulema Council has also stated that the vaccine is holy and lawful so that it can be used for the vaccination program in Indonesia.
The CoronaVac vaccine, like other Covid-19 vaccines currently available, requires two injection doses for each recipient to strengthen the immune response from the first dose of injection. A total of 0.5 milliliter doses of vaccine are injected at each injection.
For information, a number of representatives who received the first dose of vaccine with the President two weeks ago and declared that they met the health requirements to participate in vaccination returned to receive the second dose of injection.
The names of the representatives who attended the first vaccination session with the President this morning were Daeng Mohammad Faqih (Chairman of PB IDI), Amirsyah Tambunan (Secretary General of MUI who also represented Muhammadiyah), Ahmad Ngisomudin (Rois Syuriah PBNU), Marshal Hadi Tjahjanto (TNI Commander ), General Pol. Idham Azis (Kapolri), and Raffi Ahmad (youth representatives).
Apart from the six people above, a number of representatives also appeared to be present at the first vaccination in the sessions that followed. Those who attended were Budi Gunadi Sadikin (Minister of Health), Unifah Rosyidi (General Chair of PGRI), Ronald Rischard Tapilatu (Association of Churches in Indonesia), and Father Agustinus Heri Wibowo (Indonesian Bishops’ Conference).
In addition, other representatives were also included, namely Penny Kusumastuti Lukito (Head of BPOM), Rosan Perkasa Roeslani (Chairman of Kadin), Ade Jubaedah (Secretary General of the Indonesian Midwives Association), Harif Fadhillah (Chairperson of the PPNI DPP), Agustini Setiyorini (labor representative), and Narti (merchant representative).
In addition, the Spokesperson for the Covid-19 Handling Task Force Prof. Wiku Adisasmito and dr. Reisa Broto Asmoro participated in this second dose of vaccination.
After injecting the vaccine, both to the President and representatives, first an observation for 30 minutes is carried out to monitor the possibility of a Post-Immunization Joining Event (AEFI). All vaccine recipients were also given outreach to keep strict health protocols applied.